CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 142 filers reported holding CYMABAY THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.69 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $36,230,167 | +20072.0% | 2,429,924 | +11697.5% | 0.11% | +10500.0% |
Q1 2023 | $179,606 | -82.6% | 20,597 | -94.1% | 0.00% | -75.0% |
Q2 2022 | $1,033,000 | -55.1% | 350,000 | -48.6% | 0.00% | -55.6% |
Q4 2021 | $2,303,000 | +14.5% | 681,401 | +18.2% | 0.01% | -30.8% |
Q2 2020 | $2,012,000 | -87.6% | 576,638 | -81.8% | 0.01% | -86.9% |
Q3 2019 | $16,182,000 | -44.9% | 3,160,600 | -22.9% | 0.10% | -35.3% |
Q2 2019 | $29,346,000 | +1597.3% | 4,098,630 | +1765.4% | 0.15% | +1812.5% |
Q4 2018 | $1,729,000 | +110.3% | 219,715 | +196.1% | 0.01% | +166.7% |
Q3 2018 | $822,000 | -27.8% | 74,197 | -91.2% | 0.00% | -66.7% |
Q1 2016 | $1,139,000 | -34.9% | 843,800 | -18.5% | 0.01% | -35.7% |
Q4 2015 | $1,750,000 | -12.8% | 1,035,288 | 0.0% | 0.01% | -12.5% |
Q3 2015 | $2,008,000 | +27.6% | 1,035,288 | +76.9% | 0.02% | +45.5% |
Q2 2015 | $1,574,000 | -61.1% | 585,288 | 0.0% | 0.01% | -60.7% |
Q1 2015 | $4,050,000 | -27.9% | 585,288 | +2.5% | 0.03% | -28.2% |
Q4 2014 | $5,614,000 | – | 571,088 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management III, LLC | 1,641,804 | $7,454,000 | 6.54% |
COMMODORE CAPITAL LP | 2,983,513 | $13,545,000 | 5.40% |
Foresite Capital Management IV, LLC | 1,787,094 | $8,113,000 | 0.97% |
Avoro Capital Advisors LLC | 10,300,000 | $46,762,000 | 0.81% |
Boxer Capital, LLC | 4,000,000 | $18,160,000 | 0.62% |
Sio Capital Management, LLC | 562,339 | $2,553,000 | 0.52% |
ACUTA CAPITAL PARTNERS, LLC | 315,341 | $1,432,000 | 0.52% |
CM Management, LLC | 150,000 | $681,000 | 0.51% |
APIS CAPITAL ADVISORS, LLC | 120,000 | $545,000 | 0.50% |
Versant Venture Management, LLC | 543,753 | $2,469,000 | 0.48% |